van Lanschot JJB - Search Results

1

Accuracy of ¹⁸F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.

Valkema MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, Biermann K, Lagarde SM, Bennink RJ, Schreurs WMJ, Roef MJ, Hobbelink MGG, Janssen MJR, Graven LH, van Lanschot JJB, Valkema R. Valkema MJ, et al. Among authors: van lanschot jjb. J Nucl Med. 2019 Nov;60(11):1553-1559. doi: 10.2967/jnumed.118.224196. Epub 2019 Mar 15. J Nucl Med. 2019. PMID: 30877177 Free article. Clinical Trial.

2

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.

Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ. Hulscher JB, et al. N Engl J Med. 2002 Nov 21;347(21):1662-9. doi: 10.1056/NEJMoa022343. N Engl J Med. 2002. PMID: 12444180 Free article. Clinical Trial.

3

Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.

Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Buskens CJ, et al. Gastrointest Endosc. 2004 Nov;60(5):703-10. doi: 10.1016/s0016-5107(04)02017-6. Gastrointest Endosc. 2004. PMID: 15557945

4

Incidence and management of chyle leakage after esophagectomy.

Lagarde SM, Omloo JM, de Jong K, Busch OR, Obertop H, van Lanschot JJ. Lagarde SM, et al. Ann Thorac Surg. 2005 Aug;80(2):449-54. doi: 10.1016/j.athoracsur.2005.02.076. Ann Thorac Surg. 2005. PMID: 16039184

5

Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer.

van Westreenen HL, Westerterp M, Jager PL, van Dullemen HM, Sloof GW, Comans EF, van Lanschot JJ, Wiggers T, Plukker JT. van Westreenen HL, et al. J Nucl Med. 2005 Aug;46(8):1321-5. J Nucl Med. 2005. PMID: 16085589 Free article. Clinical Trial.

6

Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review.

Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, Jager PL, Van Eck-Smit BL, Plukker JT, van Lanschot JJ, Sloof GW. Westerterp M, et al. Radiology. 2005 Sep;236(3):841-51. doi: 10.1148/radiol.2363041042. Radiology. 2005. PMID: 16118165 Review.

7

Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction.

Lagarde SM, ten Kate FJ, de Boer DJ, Busch OR, Obertop H, van Lanschot JJ. Lagarde SM, et al. Am J Surg Pathol. 2006 Feb;30(2):171-6. doi: 10.1097/01.pas.0000189182.92815.12. Am J Surg Pathol. 2006. PMID: 16434890

8

Association of no epidural analgesia with postoperative morbidity and mortality after transthoracic esophageal cancer resection.

Cense HA, Lagarde SM, de Jong K, Omloo JM, Busch OR, Henny ChP, van Lanschot JJ. Cense HA, et al. J Am Coll Surg. 2006 Mar;202(3):395-400. doi: 10.1016/j.jamcollsurg.2005.11.023. Epub 2006 Jan 27. J Am Coll Surg. 2006. PMID: 16500242

9

Role of positron emission tomography in the (re-)staging of oesophageal cancer.

Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ. Westerterp M, et al. Scand J Gastroenterol Suppl. 2006;(243):116-22. doi: 10.1080/00365520600664409. Scand J Gastroenterol Suppl. 2006. PMID: 16782630 Review.

10

Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.

Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Lagarde SM, et al. J Clin Oncol. 2006 Sep 10;24(26):4347-55. doi: 10.1200/JCO.2005.04.9445. J Clin Oncol. 2006. PMID: 16963732 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page